ClinVar Miner

Submissions for variant NM_004444.5(EPHB4):c.2044G>A (p.Val682Met)

dbSNP: rs2116431583
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
New York Genome Center RCV001839304 SCV002099290 likely pathogenic Capillary malformation-arteriovenous malformation 2 2021-04-16 criteria provided, single submitter clinical testing The de novo heterozygous c.2044G>A (p.Val682Met) variant identified in the EPHB4 gene has not been reported in affected individuals in the literature. The variant is absent from the gnomAD(v3) database suggesting it is not a common benign variant in the populations represented in that database. The variant affects an evolutionarily conserved residue and is predicted deleterious by multiple in silico prediction tools. Based on the available evidence, the de novo heterozygous c.2044G>A (p.Val682Met) variant identified in the EPHB4 gene is reported as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.